BioGenome Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioGenome Therapeutics's estimated annual revenue is currently $1.1M per year.(i)
  • BioGenome Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • BioGenome Therapeutics has 7 Employees.(i)
  • BioGenome Therapeutics grew their employee count by -36% last year.

BioGenome Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$0.3M2-78%N/AN/A
#3
$3.5M13-13%$18MN/A
#4
$1.4M9-10%N/AN/A
#5
$11.8M7627%N/AN/A
#6
$4.2M2713%N/AN/A
#7
$9.3M609%N/AN/A
#8
$300M199-13%$53MN/A
#9
$2.6M176%N/AN/A
#10
$0.6M4-20%N/AN/A
Add Company

What Is BioGenome Therapeutics?

BioGenome Therapeutics is an immunotherapy company developing methodologies to modulate genes and MiR pathways involved in cellular protection, repair and immune response.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

-36%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M7-42%N/A
#2
$0.5M7-22%N/A
#3
$0.5M7N/AN/A
#4
$0.9M7-85%N/A
#5
$0.5M70%N/A